Literature DB >> 20232048

Diagnostic utility of elevated serum soluble triggering receptor expressed on myeloid cells (sTREM)-1 in infected neonates.

Kosmas Sarafidis1, Vasiliki Soubasi-Griva, Kaliopi Piretzi, Agathi Thomaidou, Eleni Agakidou, Anna Taparkou, Elisavet Diamanti, Vasiliki Drossou-Agakidou.   

Abstract

OBJECTIVE: To assess the value of serum levels of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) for early diagnosis of late-onset sepsis (LOS) in neonates, compared with interleukin-6 (IL-6). DESIGN AND
SETTING: Prospective, observational study in a single, level III neonatal intensive care unit of a university hospital. PATIENTS: Fifty-two preterm and term neonates evaluated for suspected LOS were studied. Neonates were classified into two groups: infected [confirmed sepsis (n = 22) and possible sepsis (n = 9)] and noninfected neonates (n = 21). MEASUREMENTS AND
RESULTS: Serum sTREM-1 and IL-6 were measured (enzyme-linked immunosorbent assays) when signs suggestive of sepsis emerged. Infected neonates had significantly higher sTREM-1 (p = 0.004) and IL-6 (p < 0.0001) than noninfected neonates. Receiver operating characteristic (ROC) curve analysis resulted in significant areas under the curve (AUC) for both sTREM-1 (AUC = 0.733, p = 0.005) and IL-6 (AUC = 0.892, p = 0.001) for identification of infected neonates, with the difference between the two AUC not being significant. Further analysis documented acceptable diagnostic performance of sTREM-1 and IL-6, which was not improved, however, when the two markers were combined.
CONCLUSIONS: Serum sTREM-1 increases in infected neonates. Diagnostic accuracy of sTREM-1 either alone or in combination with IL-6 is not better than that of IL-6.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20232048     DOI: 10.1007/s00134-010-1819-3

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  18 in total

1.  Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes.

Authors:  A Bouchon; J Dietrich; M Colonna
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

2.  Circulating levels of soluble triggering receptor expressed on myeloid cells (sTREM)-1 in community-acquired pneumonia.

Authors:  Beat Müller; Mikael M Gencay; Sebastien Gibot; Daiana Stolz; Lukas Hunziker; Michael Tamm; Mirjam Christ-Crain
Journal:  Crit Care Med       Date:  2007-03       Impact factor: 7.598

3.  Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule, and C-reactive protein in preterm very low birthweight infants.

Authors:  P C Ng; S H Cheng; K M Chui; T F Fok; M Y Wong; W Wong; R P Wong; K L Cheung
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-11       Impact factor: 5.747

4.  Soluble triggering receptor expressed on myeloid cells 1: a biomarker for bacterial meningitis.

Authors:  Rogier M Determann; Martijn Weisfelt; Jan de Gans; Arie van der Ende; Marcus J Schultz; Diederik van de Beek
Journal:  Intensive Care Med       Date:  2006-06-20       Impact factor: 17.440

5.  Soluble triggering receptor expressed on myeloid cells 1 as an anti-inflammatory mediator in sepsis.

Authors:  Evangelos J Giamarellos-Bourboulis; Spyridon Zakynthinos; Fotini Baziaka; Evangelos Papadomichelakis; Simona Virtzili; Pantelis Koutoukas; Apostolos Armaganidis; Helen Giamarellou; Charis Roussos
Journal:  Intensive Care Med       Date:  2006-02-01       Impact factor: 17.440

Review 6.  Definitions of bloodstream infection in the newborn.

Authors:  Khalid N Haque
Journal:  Pediatr Crit Care Med       Date:  2005-05       Impact factor: 3.624

7.  Inflammatory mediators for the diagnosis and treatment of sepsis in early infancy.

Authors:  Malgorzata A Verboon-Maciolek; Steven F T Thijsen; Marieke A C Hemels; Marjolein Menses; Anton M van Loon; Tannette G Krediet; Leo J Gerards; Andre Fleer; Hieronymus A M Voorbij; Ger T Rijkers
Journal:  Pediatr Res       Date:  2006-03       Impact factor: 3.756

8.  Outcome and prognostic factors in neonates with septic shock.

Authors:  Elsa Kermorvant-Duchemin; Sophie Laborie; Muriel Rabilloud; Alexandre Lapillonne; Olivier Claris
Journal:  Pediatr Crit Care Med       Date:  2008-03       Impact factor: 3.624

Review 9.  Toward resolving the challenges of sepsis diagnosis.

Authors:  Shawn D Carrigan; George Scott; Maryam Tabrizian
Journal:  Clin Chem       Date:  2004-05-27       Impact factor: 8.327

10.  Comparison of broad range 16S rDNA PCR and conventional blood culture for diagnosis of sepsis in the newborn: a case control study.

Authors:  Tonje Reier-Nilsen; Teresa Farstad; Britt Nakstad; Vigdis Lauvrak; Martin Steinbakk
Journal:  BMC Pediatr       Date:  2009-01-19       Impact factor: 2.125

View more
  17 in total

1.  A meta-analysis of interleukin-6 as a valid and accurate index in diagnosing early neonatal sepsis.

Authors:  Bo Sun; Lian-Fang Liang; Jie Li; Dan Yang; Xiao-Bing Zhao; Ke-Gang Zhang
Journal:  Int Wound J       Date:  2019-02-07       Impact factor: 3.315

Review 2.  Diagnostics for neonatal sepsis: current approaches and future directions.

Authors:  Pui-Ying Iroh Tam; Catherine M Bendel
Journal:  Pediatr Res       Date:  2017-06-28       Impact factor: 3.756

3.  Pancreatic stone protein as a novel marker for neonatal sepsis.

Authors:  Luregn J Schlapbach; Rolf Graf; Andreas Woerner; Matteo Fontana; Urs Zimmermann-Baer; David Glauser; Eric Giannoni; Thierry Roger; Christoph Müller; Mathias Nelle; Martin Stocker
Journal:  Intensive Care Med       Date:  2013-01-08       Impact factor: 17.440

4.  Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding.

Authors:  Kendra N Iskander; Marcin F Osuchowski; Deborah J Stearns-Kurosawa; Shinichiro Kurosawa; David Stepien; Catherine Valentine; Daniel G Remick
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

Review 5.  Soluble TREM-1 as a predictive factor of neonatal sepsis: a meta-analysis.

Authors:  Ioannis Bellos; Georgia Fitrou; Georgios Daskalakis; Nikolaos Thomakos; Nikolaos Papantoniou; Vasilios Pergialiotis
Journal:  Inflamm Res       Date:  2018-04-11       Impact factor: 4.575

6.  Year in review in Intensive Care Medicine 2010: III. ARDS and ALI, mechanical ventilation, noninvasive ventilation, weaning, endotracheal intubation, lung ultrasound and paediatrics.

Authors:  Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; Herwig Gerlach; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Jerôme Pugin; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2011-02-03       Impact factor: 17.440

7.  Emerging biomarkers for the diagnosis of severe neonatal infections applicable to low resource settings.

Authors:  Thor A Wagner; Courtney A Gravett; Sara Healy; Viju Soma; Janna C Patterson; Michael G Gravett; Craig E Rubens
Journal:  J Glob Health       Date:  2011-12       Impact factor: 4.413

Review 8.  Accuracy of plasma sTREM-1 for sepsis diagnosis in systemic inflammatory patients: a systematic review and meta-analysis.

Authors:  Youping Wu; Fei Wang; Xiaohua Fan; Rui Bao; Lulong Bo; Jinbao Li; Xiaoming Deng
Journal:  Crit Care       Date:  2012-11-29       Impact factor: 9.097

Review 9.  Diagnostic value of soluble triggering receptor expressed on myeloid cells in paediatric sepsis: a systematic review.

Authors:  Giuseppe Pontrelli; Franco De Crescenzo; Roberto Buzzetti; Francesca Calò Carducci; Alessandro Jenkner; Donato Amodio; Maia De Luca; Sara Chiurchiù; Elin Haf Davies; Alessandra Simonetti; Elena Ferretti; Martina Della Corte; Luca Gramatica; Susanna Livadiotti; Paolo Rossi
Journal:  Ital J Pediatr       Date:  2016-04-27       Impact factor: 2.638

Review 10.  A Novel Combination of Biomarkers to Herald the Onset of Sepsis Prior to the Manifestation of Symptoms.

Authors:  Hallie H Dolin; Thomas J Papadimos; Stanislaw Stepkowski; Xiaohuan Chen; Zhixing K Pan
Journal:  Shock       Date:  2018-04       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.